Skip to main content

Table 8 Fracture Risk Reduction in Response to Therapy.

From: Management of osteoporosis

Generic Name

Brand Name

Spine Fracture

Non-Vertebral Fracture

Hip Fracture

Estrogen

Various

Alendronate

Fosamax

Risedronate

Actonel

Ibandronate

Boniva

  

Calcitonin

Miacalcin

  

Raloxifene

Evista

  

Teriparatide

Forteo

 
  1. This table illustrates the direction of change in fracture risk with each type of drug. This does not represent a comparison of the magnitude of fracture risk reduction with different drugs. While all FDA-approved medications have been shown to reduce the risk of spine fracture, only estrogen, alendronate, and risedronate have reduced the risk of hip fracture in randomized placebo-controlled trials.
Back to article page

Clinical and Molecular Allergy

ISSN: 1476-7961

Contact us